Press release
U.S. Biosimilars Market to surge at 54.7% CAGR and Hit US$ 17,696.0 Mn by 2026
Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/u-s-biosimilars-market-100990
Increased Research and Development Initiatives to Drive the Market
Biosimilars are the copies of original products. Due to the high cost of pharmaceutical drugs, healthcare facilities are not accessible to people from every economical stratum. This is where biosimilars come to recuse. Being an identical copy, biosimilars help in treating chronic diseases like cancer and arthritis in an effective manner just as original medications do. The market is likely to grow during the forecast period because of an increasing demand from the masses. Also, a rise in research and development initiatives by prominent organizations have increased market opportunities. This has led to tough competition in the U.S. biosimilars market.
Get Discount@ https://www.fortunebusinessinsights.com/enquiry/check-discount/u-s-biosimilars-market-100990
Table of content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Key Disease Associated with the Scope - U.S., 2018
4.2 New Product Launch
4.3 Pipeline Analysis
4.4 Regulatory Scenario
4.5. Reimbursement Scenario
4.6. Patent Snapshot of Biologics
4.6 Key Industry Developments - Partnerships, Mergers & Acquisitions
5. U.S. Biosimilars Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Drug Class
5.2.1 Filgrastim & Pegfilgrastim
5.2.2 Monoclonal Antibodies
5.2.2 Others
5.3. Market Analysis, Insights and Forecast – By Disease Indication
5.3.1 Cancer
5.3.2 Autoimmune Diseases
5.3.2.1 Arthritis
5.3.2.2 Psoriasis
5.3.2.3 Neutropenia
5.3.2.4 Others
5.3.3 Others
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1 Hospital Pharmacy
5.4.2 Retail Pharmacy
5.4.3 Online Pharmacy
6. Competitive Analysis
6.1. Key Industry Developments
6.2. U.S. Market Share Analysis (2018)
6.3. Competition Dashboard
6.4. Comparative Analysis – Major Players
6.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
6.5.1 Novartis AG
6.5.2 Pfizer Inc.
6.5.3 Coherus BioSciences, Inc.
6.5.4 Teva Pharmaceutical Industries Ltd.
6.5.5 Merck & Co., Inc.
6.5.6 AbbVie Inc.
6.5.7 F. Hoffmann-La Roche Ltd.
6.5.8 Eli Lilly and Company
6.5.9 Celltrion Inc.
6.5.10 Amgen Inc.
6.5.11 Other Prominent Players
7. Strategic Recommendations
Segmentation
By Drug Class
· Filgrastim & Pegfilgrastim
· Monoclonal Antibodies
· Others
By Disease Indication
· Cancer
· Autoimmune Diseases
· Arthritis
· Psoriasis
· Neutropenia
· Others
· Others
By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Biosimilars Market to surge at 54.7% CAGR and Hit US$ 17,696.0 Mn by 2026 here
News-ID: 1848003 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd.
Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% …
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period.
Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacement…
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca …
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023.
Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032."
Request a Free Sample…
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan …
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period.
Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear is…
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- …
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period.
Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost the…
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
